2021
DOI: 10.1093/eurheartj/ehab724.055
|View full text |Cite
|
Sign up to set email alerts
|

Left ventricular diastolic dysfunction in non-severe chronic obstructive pulmonary disease as a step forward in cardiovascular comorbidome

Abstract: Background Chronic obstructive pulmonary disease (COPD) augments the likelihood of having left ventricular diastolic dysfunction (LVDD) – precursor of heart failure with preserved ejection fraction (HFpEF). LVDD shares overlapping symptomatology (cough and dyspnea) with COPD. Purpose Our aim was to evaluate the predictive value of inflammatory, oxidative stress, cardio-pulmonary and echocardiographic parameters at rest for th… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…Paul found that the chance heart failure in patients with chronic obstructive pulmonary disease (COPD) is 2.17 times that of those without COPD, which is close to 1.9 times that of Truls et al [16,17]. Patients with COPD often have decreased lung function and increased lung volume, which may lead to myocardial injury and left ventricular diastolic dysfunction, inducing the occurrence of AHF [18,19]. In this study, patients with cardiac history have a 2.25-fold increased risk of AHF, compared with patients without heart disease before the injury.…”
Section: Discussionmentioning
confidence: 85%
“…Paul found that the chance heart failure in patients with chronic obstructive pulmonary disease (COPD) is 2.17 times that of those without COPD, which is close to 1.9 times that of Truls et al [16,17]. Patients with COPD often have decreased lung function and increased lung volume, which may lead to myocardial injury and left ventricular diastolic dysfunction, inducing the occurrence of AHF [18,19]. In this study, patients with cardiac history have a 2.25-fold increased risk of AHF, compared with patients without heart disease before the injury.…”
Section: Discussionmentioning
confidence: 85%
“…The development of HFpEF in patients with HTN is attributed to multifactorial processes including ventricular stiffness, ventricular-arterial coupling and myocardial fibrosis [7]. Comorbidities such as obesity, diabetes, chronic obstructive pulmonary disease, and iron deficiency anemia contribute to a systemic inflammatory state marked by an activation of interleukin 6 (IL-6), tumor necrosis factor-a (TNFa), solute suppression of tumorigenicity 2 (sST2) and Pentraxin 3 [8,9]. This leads to a stimulation of the coronary microvascular endothelium system, which in turn promotes subendothelial migration of leukocytes, produces reactive oxygen species, and reduces nitric oxide (NO) bioavailability.…”
Section: Emerging Mechanisms Contributing To the Development Of Heart...mentioning
confidence: 99%